Arbejdsgruppen vedrørende sikkerhed mødtes 5 gange i 2001 og afsluttede 11 retningslinjer enten i form af en høring eller som udkast.
EDQM, with the intent of evaluating FMD medicines so that the quality, safety and efficacy would be seen to be consistent with Community pharmaceutical legislation.